ABERNETHY MATT bought NBIX

February 12, 2026 · Form 4 insider transaction

ABERNETHY MATT bought 2,133 shares of Neurocrine Biosciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 5 days after the transaction.